https://www.thebodypro.com/article/in-battle-of-first-line-hiv-drugs-raltegravir-beat
First-Line HIV TreatmentConference Coverage

In Battle of First-Line HIV Drugs, Raltegravir Beats Two Protease Inhibitors

    Myles Helfand

    Myles Helfand

    @MylesatTheBody

    Myles Helfand is the executive editor and general manager of TheBody/TheBodyPro.